CLV.AX

Consumer Defensive Packaged Foods

Clover Corporation Limited

A$1.03
-0.01 -1.44% today

Price History

Not enough data

Key Stats

Market Cap
172.01M
Avg Volume
116,919
P/E (TTM)
17.17
EPS
A$0.06
52W High
A$1.17
52W Low
A$0.62
Div. Yield
2.2%

Analyst Ratings

Buy
1
Str Buy
1
Buy
0
Hold
0
Sell
0
Str Sell

Valuation

Forward P/E
10.62
P/B Ratio
2.35
P/S Ratio
1.77
EV/EBITDA
9.42
EV/Revenue
1.69
PEG Ratio
2.86

Margins

Gross Margin 35.5%
Operating Margin 19.2%
Net Margin 10.7%
EBITDA Margin 18.0%

Growth & Returns

Revenue Growth (YoY)
10.2%
Earnings Growth (YoY)
33.9%
Earnings Growth (QoQ)
33.7%
Return on Equity
13.9%
Return on Assets
11.1%

Liquidity & Leverage

Current Ratio
3.73
Quick Ratio
1.26
Debt / Equity
0.01
Total Cash
7.22M
Total Debt
1.07M

About

Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega's Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. It offers its products in dry powder form. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.

www.clovercorp.com.au